Issuer: Immunic, Inc. / Key word(s): Conference Immunic, Inc. to Participate in Investor Conferences in September 01.09.2022 / 12:30 CET/CEST The issuer is solely responsible for
/PRNewswire/ Immunic, Inc. (Nasdaq: IMUX), a clinical-stage biopharmaceutical company developing a pipeline of selective oral immunology therapies focused.
Salarius Pharmaceuticals to Present at the Virtual Ladenburg Thalmann Healthcare Conference apnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from apnews.com Daily Mail and Mail on Sunday newspapers.